Servier Canada and the New Brunswick Health Research Foundation announce the creation of the Servier-New Brunswick Cardiac Health Improvement Fund (CHIF) Français
SAINT JOHN, Jan. 15, 2018 /CNW Telbec/ - Servier Canada and the New Brunswick Health Research Foundation, announced the creation of the Servier New-Brunswick Cardiac Health Improvement Fund (SC-NB-CHIF). The $1.5M fund will promote health research and health innovation in the field of cardiovascular diseases in New Brunswick.
"Today marks another important milestone towards improving cardiac care within the province of New Brunswick" said Health Minister Benoît Bourque. "Putting money into research that will advance health care services related to cardiovascular disease will improve the quality of life for New Brunswickers".
"Servier Canada is proud to partner with the New Brunswick Health Research Foundation. The interconnections between different actors in this province creates a unique ecosystem, a real living lab, which is very supportive of health innovation. This joint initiative demonstrates how different actors from the public and the private sector can join forces to create better value for patients as well as for the health care system of New-Brunswick » stated Frederic Fasano, Chief Executive Officer of Servier Canada.
"We say thank you to Servier Canada and its leadership in becoming a biopharmaceutical partner that we engage with to strategically position New Brunswick as a leader in biomedical and clinical innovations", mentioned Dr Bruno Battistini, President, CEO and Scientific Director for the NBHRF. "We believe that there is no better way to develop, study and validate new medications than with real-world evidence in clinic and that such evidence will validate the usefulness, savings and sustainability of healthcare systems vis-a-vis new medications for better patients-centred care and their quality of life", he added.
About Servier Canada
Servier Canada Inc., headquartered in Laval, Quebec, is the third largest affiliate by turnover of Servier Group. It belongs to the top 20 research-based pharmaceutical companies in Canada. Servier Canada is currently marketing five cardiovascular medicines and is expecting further approvals in other therapeutic areas, like Oncology in the coming months. The mission of Servier Canada is to provide the Canadian medical community and their patients with innovative therapeutic solutions in differents therapeutic areas of high unmet needs, like cardiology, diabetes or oncology. Servier Canada collaborates with various stakeholders including researchers, biotech entrepreneurs and innovators. In addition to these partnerships, the Center of Excellence in Clinical Research of Servier Canada is dedicated to clinical development with more than 50 trials conducted throughout Canada in the last 10 years. More information is available at www.servier.ca
About the New Brunswick Health Research Foundation
The NBHRF (nbhrf.com / @NBHRF) is an independent organization governed by a board of directors comprised of key stakeholders from the health research community in New Brunswick. Provincial funding is provided by the Regional Development Corporation – Total Development Fund, the Department of Health - Medical Research Fund (MRF) and the Department of Social Development - Wellness Research Fund (WRF) for NBHRF health research programs (HRP), health strategic initiatives (HRI) with federal tri-councils, national health charities and private sector, and the Strategic Investment in Health Research Innovations (SIHRI). The foundation's mission is to provide leadership and support building health research capacity, improve the health of New Brunswickers and advance the knowledge economy.
SOURCE Servier Canada Inc.
Servier Canada Inc., Nadine Doucet, Office (450) 978-9700, Ext: 4225, [email protected]; New Brunswick Health Research Foundation, Patricia Seaman, Senior Communications Officer, New Brunswick Health Research Foundation, Office (506) 455-0471, Cell (506) 476-5327, [email protected]
Share this article